June 17, 2020 09:41 AM EDT

Merck eats the lunch Bristol Myers never served, winning TMB-based OK for Keytruda

Amber Tong

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

ENDPOINTS CAREERS

VP, Clinical Development / CMO / CDO‬ ‭ (Stealth Portfolio Company)

Autonomy Bio Inc.

San Francisco, CA 94107, USA

view job offer post your job now

TRENDING NOW

CRISPR patent spat revived by federal appeals court ruling

TIGIT graveyard expands as GSK drops late-stage asset with iTeos

UnitedHealth Group CEO Andrew Witty steps down

Updated: To spin off or not to spin off? Galapagos backpedals on separation plans, CEO Paul Stoffels exits early

HHS focuses on 'transparency' in third-round IRA negotiation guidance

Bayer starts 2025 by cutting 2,000 jobs as it homes in on year-end rehaul target